Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
OLMA

OLMA - Olema Pharmaceuticals Inc Stock Price, Fair Value and News

$15.06-0.06 (-0.40%)
Delayed

Price Targets

OLMA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

OLMA Price Action

Last 7 days

6.7%

Last 30 days

-35.7%

Last 90 days

-40.4%

Trailing 12 Months

352.3%

OLMA RSI Chart

OLMA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

OLMA Valuation

Market Cap

1.3B

Price/Earnings (Trailing)

-8.08

Price/Free Cashflow

-9.84

OLMA Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

OLMA Fundamentals

OLMA Earnings

Earnings (TTM)

-162.5M

Earnings Growth (Yr)

-37.22%

Earnings Growth (Qtr)

-9.11%

OLMA Profitability

Return on Equity

-33.95%

Return on Assets

-30.45%

Free Cashflow Yield

-10.16%

OLMA Investor Care

Shares Dilution (1Y)

27.55%

Diluted EPS (TTM)

-1.87

OLMA Alerts

  • 1 major insider sales recently.

About Olema Pharmaceuticals Inc

OLMA
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; and OP-1250 combine with CDK4/6 inhibitors palbociclib, ribociclib, and alpelisib in Phase 1b/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
 CEO
 WEBSITEhttps://olema.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES67

Olema Pharmaceuticals Inc Frequently Asked Questions

OLMA is the stock ticker symbol of Olema Pharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu Apr 02 2026, market cap of Olema Pharmaceuticals Inc is 1.31 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.